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ABSTRACT
C. TRACHOMATIS (CT) infections of the upper genital tract in women are either acute, sub acute
or chronic. CT infection has a tendency to be chronic, latent and persistent as a consequence of the
hostimmune reaction toCTmajoroutermembrane protein, 57Kdheatshock protein and lipopolysac-
charide. Chlamydial persistence can be induced as a result ofinflammatory and/orimmune regulated
cytokines, Interferon , depletion of tryptophan causes a stress response involving development of
abnormal forms with increased levels of stress response proteins which maintain host immune re-
sponses with continuous fibrin exudate.
Themain clinicalconsequences are acute and chronic pelvic inflammatory disease, with infertility,
ectopic pregnancy and, less frequently, chronic pelvic pain as late sequelae.
PID, when acute, is marked by bilateral pelvic pain, plus other infectious signs in typical cases:
fever, leucorrhea, red and purulent cervix. In 50% cases, infectious signs are slight or absent or there
is an atypical clinical situation. Laparoscopy is the key for diagnosis. It allows the surgeon to have a
direct look at the pelvic organs and perform microbiologic and histologic sampling. In severe cases,
laparoscopy allows the surgeon to aspirate the purulent discharge and successfully treat pelvic ab-
scesses.
Chronic PID usually is clinically silent. It is in most cases discovered some years after the onset of
CT infection, in women operated on for tubal infertility or ectopic pregnancy. Further studies, to
evaluate treatments efficiency in chronic cases and factors leading to ectopic pregnancy or to recur-
rence, are indicated. (C) 1996 Wiley-Liss, Inc.
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trachomatis (CT) serotypes D-K infections
of the upper genital tract in women are
either acute, sub acute or chronic. Due to the ascent
of the bacteria from the cervix to the endometrium
and Fallopian tubes, the main clinical consequences
are acute and chronic pelvic inflammatory disease
(PID), with infertility, ectopic pregnancy and, less
frequently, chronic pelvic pain as late sequelae. 1,2
CT infection is involved in 60% ofacute salpingi-
tis and ectopic pregnancies and 80% of tubal infer-
tility cases. 2’4
CT infection has a tendency to be chronic, latent
and persistent. This immunopathogenesis is a con-
sequence of the host immune reaction to CT. This
obligate intracellular organism, with a slow repro-
ductive cycle, generates an inflammatory host cas-
cade due to its major outer membrane protein
(MOMP), 57 Kd heat shock protein, which is a
member of the family of 60 kD heat shock proteins
(hsp 60) and lipopolysaccharide (LPS). Host immu-
nity to CT hsp60 is associated with upper and not
to low genital tract infection (cervix, vagina), as
shown by Witkin. This response is both protective
and pathological. MOMP is a likely protection-
mediating antigen and a good candidate for vaccine,
but this immune protection is serotype-specific and
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of short duration. Hsp 60 is probably the pathogen-
esis-inducing antigen. Among the immune cascade
multiple reactions of primary importance are: 1) the
T lymphocyte’s and macrophage’s production of
cytokines: IL4, IL6, Tumor Necrosis Factor
(TNF), Interferon gamma (IFNy) and 2) the genital
and peritoneal tissues production of fibrin exudate.
In vitro studies have shown IFNy able to block
the reproductive cycle of CT from elementary to
reticulate bodies, probably by depleting trypto-
phan. The reproductive cycle starts again if this
amino acid is added to the culture. A local immune
response (T cells, IFNy... has been found in
endometrial biopsies ofwomen with tubal infertility
or with a past history of chlamydial infection.
In some cases, the inflammatory cascade is of
benefit, generating clinical signs which lead to diag-
nosis and, with antibiotic help, obtaining the organ-
ism destruction and host recovery.
In other cases, CT infection either turns from
acute to chronic, or is primarily chronic. Chlamydial
persistence can be induced as a result of inflamma-
tory and/or immune regulated cytokines,
1 IFNy
depletion of tryptophan causes a stress response
involving development of abnormal forms with in-
creased levels of stress response proteins. These
altered CT antigens persist in the tissues and more
particularly in tubal submucosa, l’z their presence
continuing to maintain the immune host reaction.
Furthermore, the CT membrane stress proteins,
more particularly hsp 60, generate a host delayed
immune hypersensitivity and maintain susceptibil-
ity to the inflammatory reaction and to reactivation
by other antigens with amino acid homology to chla-
mydial hsp:s, such as E. coli GroEJ, GruEL and
DnaK-like proteins.
3 This slow inflammatory pro-
cess has as a consequence a continuous fibrin pro-
duction. Tubal and pelvic damages are mainly due
to fibroid exudate, either liquid in the cul-de-sac
of Douglas, or solid, creating light or dense and
thick adhesions glueing together ovaries and tubes
and both to parietal peritoneum, uterus or bowels,
glueing together tubal fimbria fringes and causing
various degrees of tubal obstruction.4 In other
cases, the immune reaction remains very slight,
without tubal occlusion, but mucosa ciliae are al-
tered with defects in oocyte transport through the
oviduct and ectopic pregnancies or, possibly, early
spontaneous abortions as consequences.
The reasons why inflammatory responses lead
to either acute, sub acute or chronic conditions is
unclear to date. This can depend on the specificity
ofCT subgroups, or, more probably, on the coinci-
dence between 1) number and frequency of re-
peated CT infections and 2) genetic variability of
the host immune responses. While DHS reactions
are relatively common, the potential to develop an
auto immune tubal inflammatory response is possi-
ble only in women genetically determined to recog-
nize the conserved epitopes of the hsp:s.
3 The true
nature ofCT chronic disease pathogenesis possibly
involves repeated infection superimposed upon
persistent infection which would allow for height-
ened immune reactivity to conserved antigens, irre-
spective of the infective serovar.
Clinical aspects of immune responses to CT in-
fection of the upper genital tracts are well known.5
CT endometritis is mostly infra clinical or leads to
a slight bleeding. PID, when acute, is marked by
bilateral pelvic pain, plus other infectious signs in
typical cases: fever, leucorrhea, red and purulent
cervix. In one case out of two, however, infectious
signs are slight or absent or there is an atypical
clinical situation: unilateral pain, adnexial mass, or
intense perihepatic pain as part of a Fitz-Hugh-
Curtis syndrome.
6 Fortunately, all practicians know
now that they have to "think PID" when a young
woman complains of pelvic pain, even if it is a
discreet or atypical one.
Diagnosis
The keys for diagnosis are: 1) biology and 2) lapar-
oscopy
Biologic infectious signs
Lymphocytosis, accelerated ESR and/or CRP are
found in 50-75% of PID; their absence, however,
does not contraindicate the diagnosis. STD detec-
tion in the lower genital tract and endometrium is
therefore mandatory, more particularly N. gonor-
rheae, CT and mycoplasmas. CT serology on sera
taken at a 3 week interval is a useful diagnosis tool.7
According to our experience,
18 antiCT IgG usually
is strongly positive and the titer is stable in 85% of
cases, but it can be negative on first serum in 5% and
evolutive on second serum in 10%. IgA is positive in
85% and evolutive in 30%, IgM is positive in 80%
of cases in our published series, antichlamydial IgM
antibody determination by immunofluorescence
using C. trachomatis-infected cells being easier to
read and yielding a higher incidence of positives
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than does immunofluorescence on purified elemen-
tary bodies. With the last method, IgM is occasion-
ally positive. Anti CT hsp 60 antibody has been
recently shown as a good marker ofCT salpingitis,
related to measures of tubal inflammation, tubal
occlusion and/or adhesions at laparoscopy.
19
Laparoscopy
Laparoscopy is the gold standard for diagnosis. How-
ever, being an invasive and costly method, it is indi-
cated mostly in atypical cases, severe cases and cases
without improvement after some days of antibiotic
treatment. Medical treatment of typical cases with 3
or more clinical and/or biological signs is recom-
mendedz and the effectiveness ofthis treatment can
be considered as a complementary diagnosis test. 15
Laparoscopy, first proposed by Jacobson and
Westrom,zl allows the surgeon to have a direct look
at the pelvic organs and perform microbiologic and
histologic intrapelvic sampling. In most cases, le-
sions are obvious: red and swollen tubes, purulent
or thick and yellow peritoneal discharge, red inflam-
matory periadnexial adhesions. A Fitz-Hugh-Curtis
syndrome with its perihepatic adhesions sometimes
is associated with CT salpingitis, even in patients
without hepatic pain. In severe cases, laparoscopy
allows the surgeon to aspirate the purulent dis-
charge and, together with a strong and polyvalent
antibiotic therapy, successfully treat pelvic ab-
scesses, zz In contrast, laparoscopic observation may
find a normal pelvis in recent or mild cases: in such
cases it is recommended to do peritoneal and tubal
micro biopsies and wait for histologic results before
eliminating a PID diagnosis. Multiple laparoscopic
sampling shows usuallyCT alone or associated with
other agents in 50-60% of PID:s.z’z3
Evolution under polyvalent antibiotic treatment
has to be followed for clinical and biological signs,
noticeably ESR and CRP decrease. The objective in
young women will be to evaluate tubal sequelae.
The chances for tubal infertility have been esti-
mated at 17% after one salpingitis, 30% after two and
60% after three or more. z4A recent Swedish study on
a cohort of women hospitalised for chlamydial con-
firmed acute PID, shows, despite accurate treat-
ment, a 5% tubal infertility risk and a 5% ectopic
pregnancy risk. z5
Chronic PID
Chronic PID usually is silent, leading to little or no
clinical pelvic pain.4’14 It is in most cases discovered
some years after the onset of CT infection, in
women operated on for tubal infertility or ectopic
pregnancy. At this time ofthe disease, CT detection
in the lower genital tract is usually negative, but has
been found positive in 5-20% of the male partners’
prostatic fluid when detected by culture or PCR
after prostatic massage,
z6CT female serology is pos-
itive for IgG and IgA without evolutivity on a sec-
ond serum. 18 Hysterosalpingography and/or laparos-
copy show the lesions: hydrosalpinx or incomplete
tubal stenosis, pelvic adhesions, often associated
with a mild degree of inflammatory reaction, that
we called "viscous pelvis ’’z’4 lightly red adhesions,
too brilliant peritoneal surfaces, viscous and yellow
liquid in the cul-de-sac. Tubal and peritoneal histol-
ogy reveals in most cases some degree of moderate
inflammation, with connective tissue oedema, lym-
phocytes and plasmocytes infiltration as described
in France by R. Palmer and J. de Bruxz7 and con-
firmed by other authors, z8
CT detection is a puzzling and unsolved problem
in those chronic cases. We obtained in several
assaysz9’3 10-30% positive cultures, and obtained iso-
lates by multiple intra-pelvic sampling and multiple
passages. Keilani et al.1 obtained similar results. CT
detection has been found positive in 30% by direct
detection, 20% by in situ hybridization on two series
of hydrosalpinx biopsies.’z In contrast, most au-
thors published negative results in such cases3z’ and
ourown assays ofCT detection byPCRon tubal sam-
pling or biopsies remained negative in most TFI
cases.34 These discrepancies are possibly due to the
very small number of altered elementary bodies or
antigen fragments disseminated in submucosal tis-
sues, as shown by hydrosalpinx biopsies electron mi-
croscopy.2 In vitro studies1 have shown this persis-
tent form as lacking ofprotective immunity antigens
(MOMP) and having a continuous production of
pathogenesis antigens (hsp 60, hsp 70), togetherwith
altered antigenic characteristics which may exacer-
bate the disease process. The antigenic composition
ofthese persistent forms, in addition to their culture-
negative characteristics, causes them to be difficult
to recognise by either standard cell culture methods
or direct antigen detection systems based on the
presence ofMOMP or LPS. In addition, when the
stimulus for persistence is removed, the quiescent
organisms resume normal growth, demonstrating
that chlamydial viability is maintained during the
persistent state.
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Treatment
Is antibiotic treatment recommended in chronicCT
infections? In several studies we found antiCT anti-
biotics inefficient, obtaining intrapelvic positive
culture or ISH detection after one to two months
of treatment, lz’z9 We observed however an improve-
ment ofviscous pelvis after a triple antibiotic associ-
ation: synthetic tetracycline plus ofloxacine for one
month, then synthetic tetracycline plus roxithro-
mycin for one month. The interest of this therapeu-
tic sequence has to be confirmed by randomised
studies with laparoscopic control.
Reparative microsurgery, mostly performed by la-
paroscopy to date, continues to be indicated in mild
cases. Its success depends on 1) degree of tubal ste-
nosis, incomplete or complete and 2) tubal mucosa
damage as objectived by endotuboscopy35’36 and
tubal biopsies. Uterine pregnancy rate after surgery
of hydrosalpinges is in the range of40% if tubal mu-
cosa is normal, less than 20% if it is damaged. IVF is
consequently often performed. The influence ofCT
infection on IVF results also is controversial. A posi-
tive antiCT serology or the presence ofantiCTHSP
antibodies is associated with IVF failure and more
particularly to ectopic pregnancies or early spontane-
ous abortions for certain authors37’38 but is ofno influ-
ence for other ones.39
Ectopic pregnancy is clinically easy to diagnose,
with its bleeding and unilateral pelvic pain associ-
ated with early pregnancy signs. Positive beta gonad-
otrophins in contrast to an empty uterus at sonogra-
phy are the keys to diagnosis. Laparoscopy is used
for both diagnosis and treatment, medical treatment
being reserved to very selected cases. Paradoxically,
most surgeons are used to correctly treating ectopics,
either in a conservative way, by salpingotomy, or
more radically, by salpingectomy, but they do not
care for evaluation of tubal damage in the tube with
ectopic nidation and the contra lateral one, nor to eti-
ological investigations that should be of interest dur-
ing and after the surgical procedure. IfCT infection
is involved in a majority of ectopics, this disease can
be relevant to other causes, such as endometriosis or
a present or past intra uterine device and, in this latter
case, has no tendency to recurrence.4 Further stud-
ies, to evaluate the different factors leading to recur-
rence in women with positiveCT serology, are indi-
cated. Positive cultures,41 positive detection of
chlamydial DNA as recently found4z in 7 of 10 tubes
with ectopic pregnancy, and presence in serum of
antibody to CT hsp60 are possible candidates to in-
fluence reproductive prognosis of a young woman
with a first ectopic pregnancy.
CONCLUSIONS
Considering the cost of PID and late sequelae, to-
gether with the doubtful efficiency of their treat-
ments, the best cost/benefit attitude is early diagno-
sis and treatment of chlamydial infection in the
lower genital tract, by systematic screening of
young people.
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